🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was an open-label, non-randomized Phase 1/2 safety study of INCAGN0187...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2016-06-20
Trial ID
NCT02697591
Treatments Being Tested
This is a phase II study of the combination of the GITR agonist monoclonal ...
Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Start Date
2020-06-23
Trial ID
NCT04225039
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and eff...
Status
Terminated
Location
The Angeles Clinic and Research Institute
Start Date
2017-11-21
Trial ID
NCT03277352
Treatments Being Tested
This is a phase Ib study with a safety lead-in (n = 6 per arm) evaluating c...
Status
Recruiting
Location
Portland Providence Medical Center
Start Date
2021-08-05
Trial ID
NCT04470024
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, efficac...
Status
Withdrawn
Location
Uab Medicine-the Kirklin Clinic
Start Date
2023-03-01
Trial ID
NCT05359692
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and eff...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2017-04-25
Trial ID
NCT03126110
Treatments Being Tested
This is a biomarker-driven trial that will enroll patients with recurrent o...
Status
Unknown
Location
CHU Saint-Pierre-Site Porte de Hal
Start Date
2017-11-16
Trial ID
NCT03088059
Treatments Being Tested